Movement Disorder Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2017 to 2026

  • Published : Nov-2017
  • Tables : 131
  • Figures : 81
  • Category : Healthcare
  • No. of Pages : 170
  • Report Code : FACT329MR
  • Format : ppt

Prevalence of the mental disorders has continued to remain high among the old aged population globally. Neurological diseases such as Huntington’s disease, Parkinson’s disease and multiple symptom atrophy (MSA) continues to propel demand for management of the movement disorders. Lack of production of brain chemical dopamine by the nerve cells in the brain leads to uncoordinated movements and mental disorders that impact the everyday activities of the persons.

global movement disorder market

According to Fact.MR, the global movement disorder market is expected to represent a value of over US$ 1,000 Mn by the end of 2026.

Market Taxonomy

Region

Product Type

End User

Application Type

North America

Rechargeable Deep Brain Stimulator Devices

Hospitals

Parkinson's Disease

Latin America

Non-rechargeable Deep Brain Stimulator Devices

Ambulatory Surgical Centers

Essential Tremor

Europe

 

Clinics

Dystonia

Japan

 

 

Refractory Epilepsy

APEJ

 

 

Obsessive Compulsive Disorder

MEA

 

 

 

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Inability to generate movements affects the functioning of nerves, brain and the spinal cord adversely. Neurological disorders has led to surge in diseases such as trauma, convulsive diseases, cerebrovascular diseases, brain tumors and degenerative diseases. Growing prevalence of such mental disorders impact the cognitive abilities and lead to increasing prevalence of insomnia, depression, swallowing, inability to chew and speaking. Surge in awareness attributed to increasing prevalence of the neurological diseases is expected to impact growth of the global movement disorders market positively.

FDA Approval to Boost Sales of Medications

Medications and treatments approved by FDA is also expected to impact growth of the global movement disorder market. Xadago (safinamide) tablets and Ingrezza capsules are two drugs that have recently cleared the FDA pipeline. Ingrezza capsules have recently received approval for treatment of dyskinesia and Xadago (safinamide) tablets have received approval of Parkinson’s disease. In addition, the FDA has also approved implantation of brain to reduce the tremor symptoms. These factors are further expected to boost growth of the global movement disorders market.

Advanced Features to Impact Growth of the Global Market

In order to gain a competitive edge, various companies operating in the global movement disorder market are focusing on product innovation and developments. Manufacturers are mainly concentrating on incorporating advanced technology in the medical devices for faster recovery and improved results. Equipped with the advanced features such as sensors, 360-degree stabilizing solutions and cloud technology. Parkinson’s spoon equipped with advanced technological features enable the end users to retrieve and store information regarding the status of the unwanted tremors and generates the algorithm of tremor patterns for optimal stabilization. Moreover, the manufacturers operating in the global market are offering the electronic stabilizing handle, which comprises everyday spoon, spork, soup spoon and a fork. Bound to these factors, the global movement disorders market is expected to witness significant growth during the forecast period.

On the other hand, various factors continue to impact growth of the global movement disorders market negatively. Lack of investment in research and development will continue to inhibit growth of the global movement disorder market. In addition, slow approval of the medications developed is further likely to impact growth of the global market negatively. Moreover, poor method of therapeutics conducted continues to pose significant challenges towards growth of the global market.

Parkinson ’s disease to Represent a Leading Segment

Growing need for medical devices with the uninterrupted functioning for treatment of the neurological disorders has led to an upsurge in adoption of rechargeable deep brain stimulator devices. On the basis of product type, the rechargeable deep brain stimulator devices segment is expected to generate significant revenues, accounting for a value of over US$ 500 Mn by the end of 2026. However, the non-rechargeable deep brain stimulator devices product type segment is expected to register the highest CAGR during the forecast period.

Based on end user, the hospitals segment is expected to represent the highest revenue growth, recording a value of less than US$ 100 Mn by the end of 2017. On the other hand, the clinics end user segment is expected to register a robust through 2026.

By application, the Parkinson’s disease segment is expected to represent a significant revenue growth, accounting for a value of over US$ 400 Mn by the end of 2026. In contrary to this, the dystonia application segment is expected to register a healthy CAGR throughout the forecast period.

Competition Tracking

Leading market players operating in the global movement disorder market include Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation and Mayo Clinic.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

Chapter 1 Global Outlook

Chapter 2 Global Movement Disorder Market - Executive Summary

Chapter 3 Global Movement Disorder Market Overview
3.1 Introduction
      3.1.1 Global Movement Disorder Market Taxonomy
      3.1.2 Global Movement Disorder Market Definition
3.2 Global Movement Disorder Market Size (US$ Mn) and Forecast, 2012-2026
      3.2.1 Global Movement Disorder Market Y-o-Y Growth
3.3 Global Movement Disorder Market Dynamics
3.4 Supply Chain
3.5 Cost Structure
3.6 Technology Roadmap
3.7 Disease Epidemiology
3.8 Product Lifecycle
3.9 Key Regulations
3.10 PESTL Analysis
3.11 List of Service Providers
3.12 Key Participants Market Presence (Intensity Map) By Region

Chapter 4 Global Movement Disorder Market Analysis and Forecast 2012-2026
4.1 Global Movement Disorder Market Size and Forecast by Product Type, 2012-2026
      4.1.1 Rechargeable Deep Brain Stimulator Devices Market Size and Forecast, 2012-2026
              4.1.1.1 Revenue (US$ Mn) Comparison, By Region
              4.1.1.2 Market Share Comparison, By Region
              4.1.1.3 Y-o-Y growth Comparison, By Region
      4.1.2 Non-rechargeable Deep Brain Stimulator Devices Market Size and Forecast, 2012-2026
              4.1.2.1 Revenue (US$ Mn) Comparison, By Region
              4.1.2.2 Market Share Comparison, By Region
              4.1.2.3 Y-o-Y growth Comparison, By Region
4.2 Global Movement Disorder Market Size and Forecast by End User, 2012-2026
      4.2.1 Hospitals Market Size and Forecast, 2012-2026
              4.2.1.1 Revenue (US$ Mn) Comparison, By Region
              4.2.1.2 Market Share Comparison, By Region
              4.2.1.3 Y-o-Y growth Comparison, By Region
      4.2.2 Ambulatory Surgical Centers Market Size and Forecast, 2012-2026
              4.2.2.1 Revenue (US$ Mn) Comparison, By Region
              4.2.2.2 Market Share Comparison, By Region
              4.2.2.3 Y-o-Y growth Comparison, By Region
      4.2.3 Clinics Market Size and Forecast, 2012-2026
              4.2.3.1 Revenue (US$ Mn) Comparison, By Region
              4.2.3.2 Market Share Comparison, By Region
              4.2.3.3 Y-o-Y growth Comparison, By Region
4.3 Global Movement Disorder Market Size and Forecast by Application Type, 2012-2026
      4.3.1 Parkinson's disease Market Size and Forecast, 2012-2026
              4.3.1.1 Revenue (US$ Mn) Comparison, By Region
              4.3.1.2 Market Share Comparison, By Region
              4.3.1.3 Y-o-Y growth Comparison, By Region
      4.3.2 Essential Tremor Market Size and Forecast, 2012-2026
              4.3.2.1 Revenue (US$ Mn) Comparison, By Region
              4.3.2.2 Market Share Comparison, By Region
              4.3.2.3 Y-o-Y growth Comparison, By Region
      4.3.3 Dystonia Market Size and Forecast, 2012-2026
              4.3.3.1 Revenue (US$ Mn) Comparison, By Region
              4.3.3.2 Market Share Comparison, By Region
              4.3.3.3 Y-o-Y growth Comparison, By Region
      4.3.4 Refractory Epilepsy Market Size and Forecast, 2012-2026
              4.3.4.1 Revenue (US$ Mn) Comparison, By Region
              4.3.4.2 Market Share Comparison, By Region
              4.3.4.3 Y-o-Y growth Comparison, By Region
      4.3.5 Obsessive Compulsive Disorder Market Size and Forecast, 2012-2026
              4.3.5.1 Revenue (US$ Mn) Comparison, By Region
              4.3.5.2 Market Share Comparison, By Region
              4.3.5.3 Y-o-Y growth Comparison, By Region

Chapter 5 North America Movement Disorder Market Size and Forecast, 2012-2026
5.1 Revenue (US$ Mn) Comparison, By Country
5.2 Revenue (US$ Mn) Comparison, By Product Type
5.3 Revenue (US$ Mn) Comparison, By End User
5.4 Revenue (US$ Mn) Comparison, By Application Type

Chapter 6 Latin America Movement Disorder Market Size and Forecast, 2012-2026
6.1 Revenue (US$ Mn) Comparison, By Country
6.2 Revenue (US$ Mn) Comparison, By Product Type
6.3 Revenue (US$ Mn) Comparison, By End User
6.4 Revenue (US$ Mn) Comparison, By Application Type

Chapter 7 Europe Movement Disorder Market Size and Forecast, 2012-2026
7.1 Revenue (US$ Mn) Comparison, By Country
7.2 Revenue (US$ Mn) Comparison, By Product Type
7.3 Revenue (US$ Mn) Comparison, By End User
7.4 Revenue (US$ Mn) Comparison, By Application Type

Chapter 8 Japan Movement Disorder Market Size and Forecast, 2012-2026
8.1 Revenue (US$ Mn) Comparison, By Country
8.2 Revenue (US$ Mn) Comparison, By Product Type
8.3 Revenue (US$ Mn) Comparison, By End User
8.4 Revenue (US$ Mn) Comparison, By Application Type

Chapter 9 APEJ Movement Disorder Market Size and Forecast, 2012-2026
9.1 Revenue (US$ Mn) Comparison, By Country
9.2 Revenue (US$ Mn) Comparison, By Product Type
9.3 Revenue (US$ Mn) Comparison, By End User
9.4 Revenue (US$ Mn) Comparison, By Application Type

Chapter 10 MEA Movement Disorder Market Size and Forecast, 2012-2026
10.1 Revenue (US$ Mn) Comparison, By Country
10.2 Revenue (US$ Mn) Comparison, By Product Type
10.3 Revenue (US$ Mn) Comparison, By End User
10.4 Revenue (US$ Mn) Comparison, By Application Type

Chapter 11 Global Movement Disorder Market – Competitive Landscape and Company Profiles
11.1 Global Movement Disorder Market – Company Share Analysis
11.2 Global Movement Disorder Market – Competitive Landscape
11.3 Global Movement Disorder Market – Company Profiles
      11.3.1 Medtronic Plc
              11.3.1.1 Company Overview
              11.3.1.2 Product Overview
              11.3.1.3 Key Financials
              11.3.1.4 Key Developments
              11.3.1.5 SWOT Analysis
      11.3.2 Abbott Laboratories Inc
              11.3.2.1 Company Overview
              11.3.2.2 Product Overview
              11.3.2.3 Key Financials
              11.3.2.4 Key Developments
              11.3.2.5 SWOT Analysis
      11.3.3 Boston Scientific Corporation
              11.3.3.1 Company Overview
              11.3.3.2 Product Overview
              11.3.3.3 Key Financials
              11.3.3.4 Key Developments
              11.3.3.5 SWOT Analysis
      11.3.4 Mayo Clinic
              11.3.4.1 Company Overview
              11.3.4.2 Product Overview

Chapter 12 Fact.MR Research Methodology

Chapter 13 Disclaimer

TABLE 1 Global Movement Disorder Market Value (US$ Mn), 2012-2017
TABLE 2 Global Movement Disorder Market Value (US$ Mn), 2018-2026
TABLE 3 Global Movement Disorder Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4 Global Rechargeable Deep Brain Stimulator Devices Segment Value (US$ Mn), By Region 2012-2017
TABLE 5 Global Rechargeable Deep Brain Stimulator Devices Segment Value (US$ Mn), By Region 2018-2026
TABLE 6 Global Rechargeable Deep Brain Stimulator Devices Segment Market Share, By Region 2012-2017
TABLE 7 Global Rechargeable Deep Brain Stimulator Devices Segment Market Share, By Region 2018-2026
TABLE 8 Global Rechargeable Deep Brain Stimulator Devices Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global Non-rechargeable Deep Brain Stimulator Devices Segment Value (US$ Mn), By Region 2012-2017
TABLE 10 Global Non-rechargeable Deep Brain Stimulator Devices Segment Value (US$ Mn), By Region 2018-2026
TABLE 11 Global Non-rechargeable Deep Brain Stimulator Devices Segment Market Share, By Region 2012-2017
TABLE 12 Global Non-rechargeable Deep Brain Stimulator Devices Segment Market Share, By Region 2018-2026
TABLE 13 Global Non-rechargeable Deep Brain Stimulator Devices Segment Y-o-Y, By Region 2017-2026
TABLE 14 Global Hospitals Segment Value (US$ Mn), By Region 2012-2017
TABLE 15 Global Hospitals Segment Value (US$ Mn), By Region 2018-2026
TABLE 16 Global Hospitals Segment Market Share, By Region 2012-2017
TABLE 17 Global Hospitals Segment Market Share, By Region 2018-2026
TABLE 18 Global Hospitals Segment Y-o-Y, By Region 2017-2026
TABLE 19 Global Ambulatory Surgical Centers Segment Value (US$ Mn), By Region 2012-2017
TABLE 20 Global Ambulatory Surgical Centers Segment Value (US$ Mn), By Region 2018-2026
TABLE 21 Global Ambulatory Surgical Centers Segment Market Share, By Region 2012-2017
TABLE 22 Global Ambulatory Surgical Centers Segment Market Share, By Region 2018-2026
TABLE 23 Global Ambulatory Surgical Centers Segment Y-o-Y, By Region 2017-2026
TABLE 24 Global Clinics Segment Value (US$ Mn), By Region 2012-2017
TABLE 25 Global Clinics Segment Value (US$ Mn), By Region 2018-2026
TABLE 26 Global Clinics Segment Market Share, By Region 2012-2017
TABLE 27 Global Clinics Segment Market Share, By Region 2018-2026
TABLE 28 Global Clinics Segment Y-o-Y, By Region 2017-2026
TABLE 29 Global Parkinson's Disease Segment Value (US$ Mn), By Region 2012-2017
TABLE 30 Global Parkinson's Disease Segment Value (US$ Mn), By Region 2018-2026
TABLE 31 Global Parkinson's Disease Segment Market Share, By Region 2012-2017
TABLE 32 Global Parkinson's Disease Segment Market Share, By Region 2018-2026
TABLE 33 Global Parkinson's Disease Segment Y-o-Y, By Region 2017-2026
TABLE 34 Global Essential Tremor Segment Value (US$ Mn), By Region 2012-2017
TABLE 35 Global Essential Tremor Segment Value (US$ Mn), By Region 2018-2026
TABLE 36 Global Essential Tremor Segment Market Share, By Region 2012-2017
TABLE 37 Global Essential Tremor Segment Market Share, By Region 2018-2026
TABLE 38 Global Essential Tremor Segment Y-o-Y, By Region 2017-2026
TABLE 39 Global Dystonia Segment Value (US$ Mn), By Region 2012-2017
TABLE 40 Global Dystonia Segment Value (US$ Mn), By Region 2018-2026
TABLE 41 Global Dystonia Segment Market Share, By Region 2012-2017
TABLE 42 Global Dystonia Segment Market Share, By Region 2018-2026
TABLE 43 Global Dystonia Segment Y-o-Y, By Region 2017-2026
TABLE 44 Global Refractory Epilepsy Segment Value (US$ Mn), By Region 2012-2017
TABLE 45 Global Refractory Epilepsy Segment Value (US$ Mn), By Region 2018-2026
TABLE 46 Global Refractory Epilepsy Segment Market Share, By Region 2012-2017
TABLE 47 Global Refractory Epilepsy Segment Market Share, By Region 2018-2026
TABLE 48 Global Refractory Epilepsy Segment Y-o-Y, By Region 2017-2026
TABLE 49 Global Obsessive Compulsive Disorder Segment Value (US$ Mn), By Region 2012-2017
TABLE 50 Global Obsessive Compulsive Disorder Segment Value (US$ Mn), By Region 2018-2026
TABLE 51 Global Obsessive Compulsive Disorder Segment Market Share, By Region 2012-2017
TABLE 52 Global Obsessive Compulsive Disorder Segment Market Share, By Region 2018-2026
TABLE 53 Global Obsessive Compulsive Disorder Segment Y-o-Y, By Region 2017-2026
TABLE 54 North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 55 North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 56 North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 57 North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 58 North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 59 North America Movement Disorder Market Value (US$ Mn), By Country 2012-2017
TABLE 60 North America Movement Disorder Market Value (US$ Mn), By Country 2018-2026
TABLE 61 North America Movement Disorder Market Value (US$ Mn), By Product Type 2012-2017
TABLE 62 North America Movement Disorder Market Value (US$ Mn), By Product Type 2018-2026
TABLE 63 North America Movement Disorder Market Value (US$ Mn), By End User2012-2017
TABLE 64 North America Movement Disorder Market Value (US$ Mn), By End User2018-2026
TABLE 65 North America Movement Disorder Market Value (US$ Mn), By Application Type2012-2017
TABLE 66 North America Movement Disorder Market Value (US$ Mn), By Application Type2018-2026
TABLE 67 Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 68 Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 69 Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 70 Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 71 Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 72 Latin America Movement Disorder Market Value (US$ Mn), By Country 2012-2017
TABLE 73 Latin America Movement Disorder Market Value (US$ Mn), By Country 2018-2026
TABLE 74 Latin America Movement Disorder Market Value (US$ Mn), By Product Type 2012-2017
TABLE 75 Latin America Movement Disorder Market Value (US$ Mn), By Product Type 2018-2026
TABLE 76 Latin America Movement Disorder Market Value (US$ Mn), By End User2012-2017
TABLE 77 Latin America Movement Disorder Market Value (US$ Mn), By End User2018-2026
TABLE 78 Latin America Movement Disorder Market Value (US$ Mn), By Application Type2012-2017
TABLE 79 Latin America Movement Disorder Market Value (US$ Mn), By Application Type2018-2026
TABLE 80 Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 81 Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 82 Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 83 Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 84 Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 85 Europe Movement Disorder Market Value (US$ Mn), By Country 2012-2017
TABLE 86 Europe Movement Disorder Market Value (US$ Mn), By Country 2018-2026
TABLE 87 Europe Movement Disorder Market Value (US$ Mn), By Product Type 2012-2017
TABLE 88 Europe Movement Disorder Market Value (US$ Mn), By Product Type 2018-2026
TABLE 89 Europe Movement Disorder Market Value (US$ Mn), By End User2012-2017
TABLE 90 Europe Movement Disorder Market Value (US$ Mn), By End User2018-2026
TABLE 91 Europe Movement Disorder Market Value (US$ Mn), By Application Type2012-2017
TABLE 92 Europe Movement Disorder Market Value (US$ Mn), By Application Type2018-2026
TABLE 93 Japan Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 94 Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 95 Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 96 Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 97 Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 98 Japan Movement Disorder Market Value (US$ Mn), By Country 2012-2017
TABLE 99 Japan Movement Disorder Market Value (US$ Mn), By Country 2018-2026
TABLE 100 Japan Movement Disorder Market Value (US$ Mn), By Product Type 2012-2017
TABLE 101 Japan Movement Disorder Market Value (US$ Mn), By Product Type 2018-2026
TABLE 102 Japan Movement Disorder Market Value (US$ Mn), By End User2012-2017
TABLE 103 Japan Movement Disorder Market Value (US$ Mn), By End User2018-2026
TABLE 104 Japan Movement Disorder Market Value (US$ Mn), By Application Type2012-2017
TABLE 105 Japan Movement Disorder Market Value (US$ Mn), By Application Type2018-2026
TABLE 106 APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 107 APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 108 APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 109 APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 110 APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 111 APEJ Movement Disorder Market Value (US$ Mn), By Country 2012-2017
TABLE 112 APEJ Movement Disorder Market Value (US$ Mn), By Country 2018-2026
TABLE 113 APEJ Movement Disorder Market Value (US$ Mn), By Product Type 2012-2017
TABLE 114 APEJ Movement Disorder Market Value (US$ Mn), By Product Type 2018-2026
TABLE 115 APEJ Movement Disorder Market Value (US$ Mn), By End User2012-2017
TABLE 116 APEJ Movement Disorder Market Value (US$ Mn), By End User2018-2026
TABLE 117 APEJ Movement Disorder Market Value (US$ Mn), By Application Type2012-2017
TABLE 118 APEJ Movement Disorder Market Value (US$ Mn), By Application Type2018-2026
TABLE 119 MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 120 MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 121 MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 122 MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 123 MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 124 MEA Movement Disorder Market Value (US$ Mn), By Country 2012-2017
TABLE 125 MEA Movement Disorder Market Value (US$ Mn), By Country 2018-2026
TABLE 126 MEA Movement Disorder Market Value (US$ Mn), By Product Type 2012-2017
TABLE 127 MEA Movement Disorder Market Value (US$ Mn), By Product Type 2018-2026
TABLE 128 MEA Movement Disorder Market Value (US$ Mn), By End User2012-2017
TABLE 129 MEA Movement Disorder Market Value (US$ Mn), By End User2018-2026
TABLE 130 MEA Movement Disorder Market Value (US$ Mn), By Application Type2012-2017
TABLE 131 MEA Movement Disorder Market Value (US$ Mn), By Application Type2018-2026

FIG. 1 Global Movement Disorder Market Market Value (US$ Mn), 2012-2017
FIG. 2 Global Movement Disorder Market Market Value (US$ Mn) Forecast, 2018-2026
FIG. 3 Global Movement Disorder Market Market Value (US$ Mn) and Y-o-Y, 2017-2026
FIG. 4 Global Rechargeable Deep Brain Stimulator Devices Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 5 Global Rechargeable Deep Brain Stimulator Devices Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 6 Global Rechargeable Deep Brain Stimulator Devices Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 7 Global Non-rechargeable Deep Brain Stimulator Devices Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 8 Global Non-rechargeable Deep Brain Stimulator Devices Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 9 Global Non-rechargeable Deep Brain Stimulator Devices Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 10 Global Hospitals Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 11 Global Hospitals Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 12 Global Hospitals Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 13 Global Ambulatory Surgical Centers Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 14 Global Ambulatory Surgical Centers Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 15 Global Ambulatory Surgical Centers Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 16 Global Clinics Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 17 Global Clinics Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 18 Global Clinics Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 19 Global Parkinson's Disease Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 20 Global Parkinson's Disease Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 21 Global Parkinson's Disease Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 22 Global Essential Tremor Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 23 Global Essential Tremor Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 24 Global Essential Tremor Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 25 Global Dystonia Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 26 Global Dystonia Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 27 Global Dystonia Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 28 Global Refractory Epilepsy Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 29 Global Refractory Epilepsy Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 30 Global Refractory Epilepsy Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 31 Global Obsessive Compulsive Disorder Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 32 Global Obsessive Compulsive Disorder Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 33 Global Obsessive Compulsive Disorder Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 34 North America Movement Disorder Market Market Value (US$ Mn), By Country 2012-2017
FIG. 35 North America Movement Disorder Market Market Value (US$ Mn), By Country 2018-2026
FIG. 36 North America Movement Disorder Market Market Value (US$ Mn), By Product Type 2012-2017
FIG. 37 North America Movement Disorder Market Market Value (US$ Mn), By Product Type 2018-2026
FIG. 38 North America Movement Disorder Market Market Value (US$ Mn), By End User2012-2017
FIG. 39 North America Movement Disorder Market Market Value (US$ Mn), By End User2018-2026
FIG. 40 North America Movement Disorder Market Market Value (US$ Mn), By Application Type2012-2017
FIG. 41 North America Movement Disorder Market Market Value (US$ Mn), By Application Type2018-2026
FIG. 42 Latin America Movement Disorder Market Market Value (US$ Mn), By Country 2012-2017
FIG. 43 Latin America Movement Disorder Market Market Value (US$ Mn), By Country 2018-2026
FIG. 44 Latin America Movement Disorder Market Market Value (US$ Mn), By Product Type 2012-2017
FIG. 45 Latin America Movement Disorder Market Market Value (US$ Mn), By Product Type 2018-2026
FIG. 46 Latin America Movement Disorder Market Market Value (US$ Mn), By End User2012-2017
FIG. 47 Latin America Movement Disorder Market Market Value (US$ Mn), By End User2018-2026
FIG. 48 Latin America Movement Disorder Market Market Value (US$ Mn), By Application Type2012-2017
FIG. 49 Latin America Movement Disorder Market Market Value (US$ Mn), By Application Type2018-2026
FIG. 50 Europe Movement Disorder Market Market Value (US$ Mn), By Country 2012-2017
FIG. 51 Europe Movement Disorder Market Market Value (US$ Mn), By Country 2018-2026
FIG. 52 Europe Movement Disorder Market Market Value (US$ Mn), By Product Type 2012-2017
FIG. 53 Europe Movement Disorder Market Market Value (US$ Mn), By Product Type 2018-2026
FIG. 54 Europe Movement Disorder Market Market Value (US$ Mn), By End User2012-2017
FIG. 55 Europe Movement Disorder Market Market Value (US$ Mn), By End User2018-2026
FIG. 56 Europe Movement Disorder Market Market Value (US$ Mn), By Application Type2012-2017
FIG. 57 Europe Movement Disorder Market Market Value (US$ Mn), By Application Type2018-2026
FIG. 58 Japan Movement Disorder Market Market Value (US$ Mn), By Country 2012-2017
FIG. 59 Japan Movement Disorder Market Market Value (US$ Mn), By Country 2018-2026
FIG. 60 Japan Movement Disorder Market Market Value (US$ Mn), By Product Type 2012-2017
FIG. 61 Japan Movement Disorder Market Market Value (US$ Mn), By Product Type 2018-2026
FIG. 62 Japan Movement Disorder Market Market Value (US$ Mn), By Application Type2012-2017
FIG. 63 Japan Movement Disorder Market Market Value (US$ Mn), By End User2018-2026
FIG. 64 Japan Movement Disorder Market Market Value (US$ Mn), By Application Type2012-2017
FIG. 65 Japan Movement Disorder Market Market Value (US$ Mn), By Application Type2018-2026
FIG. 66 APEJ Movement Disorder Market Market Value (US$ Mn), By Country 2012-2017
FIG. 67 APEJ Movement Disorder Market Market Value (US$ Mn), By Country 2018-2026
FIG. 68 APEJ Movement Disorder Market Market Value (US$ Mn), By Product Type 2012-2017
FIG. 69 APEJ Movement Disorder Market Market Value (US$ Mn), By Product Type 2018-2026
FIG. 70 APEJ Movement Disorder Market Market Value (US$ Mn), By End User2012-2017
FIG. 71 APEJ Movement Disorder Market Market Value (US$ Mn), By End User2018-2026
FIG. 72 APEJ Movement Disorder Market Market Value (US$ Mn), By Application Type2012-2017
FIG. 73 APEJ Movement Disorder Market Market Value (US$ Mn), By Application Type2018-2026
FIG. 74 MEA Movement Disorder Market Market Value (US$ Mn), By Country 2012-2017
FIG. 75 MEA Movement Disorder Market Market Value (US$ Mn), By Country 2018-2026
FIG. 76 MEA Movement Disorder Market Market Value (US$ Mn), By Product Type 2012-2017
FIG. 77 MEA Movement Disorder Market Market Value (US$ Mn), By Product Type 2018-2026
FIG. 78 MEA Movement Disorder Market Market Value (US$ Mn), By End User2012-2017
FIG. 79 MEA Movement Disorder Market Market Value (US$ Mn), By End User2018-2026
FIG. 80 MEA Movement Disorder Market Market Value (US$ Mn), By Application Type2012-2017
FIG. 81 MEA Movement Disorder Market Market Value (US$ Mn), By Application Type2018-2026

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benefits of Becoming a Fact.MR Client

  • Access to our global market coverage
  • Periodic updates on your sector
  • Exclusive discounts and offers
  • Greater flexibility for customization
  • Quick-research assistance for ad-hoc needs
  • Access to credible insights Fact.MR analyst interactions
  • Access to Fact.MR tools and research to fuel strategy development